Dr. Jason Saylor, DO
Board-certified in family medicine, Chief Medical Officer
Video visits across Florida · in person in Tampa (Carrollwood)
GLP-1 Weight Loss · Telehealth for Florida residents
Lab-first GLP-1 care by secure video, with a family medicine physician and real follow-up.

You’ll see Dr. Jason Saylor, DO.
Start here
Request a video visit
Tell us how to reach you. We confirm your coverage before your first visit.
Quick answer
Telehealth GLP-1 weight loss at Ascend Mind and Body is run by Dr. Jason Saylor, DO, a board-certified family medicine physician. Labs at a Quest or LabCorp near you come before any prescription, and dose titration and follow-ups run by secure video for Florida residents. We tell you before booking whether your first visit needs to be in person at our Tampa (Carrollwood) office. We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you.
Send the form or call (813) 670-3331. A care coordinator calls you back, usually within one business day, and confirms your coverage before your first visit.
Labs at a Quest or LabCorp near you check whether a GLP-1 is safe and appropriate for you.
If you start a medication, video follow-ups track side effects and adjust the dose step by step.
The clinician who will see you.
Board-certified in family medicine, Chief Medical Officer
Video visits across Florida · in person in Tampa (Carrollwood)
Booking opens the clinician’s Zocdoc calendar in a new tab, set to new-patient video visits. Prefer to talk to someone first? Use the form and a care coordinator will call you.
Telehealth visits are for patients who are physically in Florida at the time of the visit. Florida residents only.
Looking into semaglutide near you usually means weighing it against tirzepatide. The two are related but not interchangeable, and the differences matter when Dr. Jason Saylor, DO, decides which one suits your history.
Neither medicine is the right answer for everyone. Your other conditions, the medicines you already take and how your stomach handles the first doses all shape the choice. Our guide on choosing between semaglutide and tirzepatide goes deeper.
The weight-management labels are written for two groups of adults: people with obesity, and people with overweight plus at least one weight-related health condition. In the studies behind those labels, obesity meant a BMI of 30 or higher and overweight meant a BMI of 27 or higher. Weight-related conditions include high blood pressure, type 2 diabetes, high cholesterol and sleep apnea. Tirzepatide follows the same pattern.
Clearing the BMI line starts the conversation; it does not settle it. Before any prescription, Dr. Saylor goes through your history and sends blood work to a Quest or LabCorp close to home, then screens for anything that rules a GLP-1 out or calls for extra care:
If neither medicine fits, you will hear why, along with what else can help. More detail is in our guide to who qualifies for a GLP-1.
Nobody starts on the dose they will end up on. Both labels build the dose in steps, and the stated reason is to lower the risk of stomach and gut side effects. Each step gives your body time to adjust before the next increase.
For the semaglutide injection, the label starts at 0.25 mg once a week for four weeks, then moves to 0.5 mg, 1 mg and 1.7 mg, four weeks at each, with a maintenance dose from week 17 on. Tirzepatide starts at 2.5 mg once a week for four weeks and goes up 2.5 mg at a time, with at least four weeks on each dose. The semaglutide dosage chart lays the steps out week by week.
Before a step up, you and Dr. Saylor check in by secure video. Expect questions like these:
If a dose is hard on you, there is no prize for pushing through. The semaglutide label allows holding the next increase for four weeks when a dose is not tolerated, and staying put a little longer is a normal part of finding the dose that works for you. For help with the shots themselves, see where and how to inject a GLP-1.
The side effects people notice most are digestive: nausea, diarrhea, vomiting, constipation, stomach pain and indigestion. Fatigue appears on both labels as well. These tend to track with the dose, which is one more reason the dose rises gradually.
Our guide to GLP-1 side effects goes through what is normal in more detail.
Ascend Mind and Body prescribes commercially manufactured semaglutide and tirzepatide by default. A compounded version is considered only when there is a documented medical reason specific to you: for example, you react to an inactive ingredient in the manufactured product, or you need a strength that no manufacturer makes.
The reason is straightforward. A compounded preparation can vary from one pharmacy to the next in ways a manufactured product does not, and adverse events, some requiring hospital care, have been reported that may be related to dosing errors with compounded GLP-1 products.
If compounding ever comes up for you, Dr. Saylor explains what it means before any prescription is written. Our guide to brand-name semaglutide shows how to make sure you are getting the genuine medicine.
By secure video anywhere in Florida, or in person at our office.
By video
GLP-1 weight loss by video near you

In person
We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you.
Insurance questions go to our care team, who confirm your coverage with you before your first visit.
Searching for semaglutide in Florida turns up dozens of online programs, and they do not all practice medicine the same way. These checks take a few minutes, and they apply to any provider you are weighing, including this one.
Here, the physician behind the program is Dr. Jason Saylor, DO, who practices under a Florida medical license. He is the one who reviews your labs, decides whether a prescription is appropriate and sets each dose step, so you know exactly whose judgment you are relying on.
For most of the program, yes: lab review, dose titration and follow-ups run by secure video for patients in Florida. We tell you before booking whether your first visit needs to be in person at our Tampa (Carrollwood) office.
Adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea, fit the weight-management labeling. You also need to be physically in Florida for each visit, and your history and labs have to clear the screen: no personal or family history of medullary thyroid cancer or MEN 2, no current or planned pregnancy, and a careful look at pancreatitis, gastroparesis and any insulin or sulfonylurea you take.
At a Quest or LabCorp near you anywhere in Florida. The order comes from us and the results come back to us.
Yes. Telehealth visits are for patients who are physically in Florida at the time of the visit.
We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you. Insurance questions go to our care team, who confirm your coverage with you before your first visit.
Both. The first evaluation is a visit with Dr. Saylor, usually by secure video, and in some cases in person at the Tampa (Carrollwood) office; the care team tells you which before you book. Labs at a Quest or LabCorp near you come next, and nothing is prescribed until the results are back and reviewed with you. After that, dose increases and check-ins run by video for patients in Florida.
At a licensed pharmacy. Florida requires most prescriptions to be sent electronically, so if a GLP-1 is prescribed, Dr. Saylor sends it straight to the pharmacy and you collect it there or arrange delivery with that pharmacy. Before the first injection, the care team confirms which pharmacy you are using and that your starting dose is the one on the prescription. Ask the pharmacist how to store the pens, especially on hot Florida days.
Bulk copies are not. Federal law lets pharmacies compound copies of an approved drug at scale only while that drug is in shortage, and the FDA declared the semaglutide injection shortage resolved in February 2025, with wind-down periods that ran into spring 2025. A licensed pharmacy can still compound for one patient when a prescriber documents a medical need, such as an allergy to an inactive ingredient. Compounded versions are not FDA approved, and here they are considered only for that kind of documented reason.
Yes, when it is done properly. Section 456.47 of the Florida Statutes lets a licensed clinician evaluate and treat a patient by telehealth and holds that care to the same professional standard as an in-person visit. The statute's limit on prescribing by video applies to Schedule II controlled substances. Semaglutide and tirzepatide are not controlled substances, so a Florida physician may prescribe them after a video evaluation thorough enough to support the decision. You do need to be physically in Florida during each visit.
Florida also requires prescriptions to be transmitted electronically in most cases. If a GLP-1 is prescribed, it goes from Dr. Saylor to a licensed pharmacy, and which pharmacy, and whether it has your starting dose on hand, is settled with you before the first injection.
The law sets the floor; the labs are a medical choice. Before any prescription, blood drawn at a Quest or LabCorp near you checks:
None of that shows up on a questionnaire, which is the plain reason a prescription waits for results.
Send a request and a care coordinator will call you back, or call us now. Insurance questions go to our care team, who confirm your coverage with you before your first visit.